Related Experiment Video
Updated: Aug 16, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Impaired endothelial function in coronary heart disease patients with depressive symptomatology
Andrew Sherwood1, Alan L Hinderliter, Lana L Watkins
1Duke University Medical Center, Durham, North Carolina 27710, USA. sherw002@mc.duke.edu
Insights
Depressive symptoms in coronary heart disease (CHD) patients are linked to poorer vascular endothelial function. Antidepressant use may improve this endothelial dysfunction, potentially reducing cardiovascular event risk.
Area of Science:
- Cardiology
- Psychiatry
- Vascular Biology
Background:
- Depression significantly increases mortality risk in coronary heart disease (CHD) patients.
- Underlying mechanisms linking depression and mortality in CHD remain unclear.
- Endothelial dysfunction is a known risk factor for cardiovascular events in CHD.
Purpose of the Study:
- To investigate the association between depressive symptomatology and vascular endothelial dysfunction in patients with CHD.
- To explore potential pathways linking depression and cardiovascular risk in CHD.
Main Methods:
- Assessed endothelial function using flow-mediated dilation (FMD) of the brachial artery.
- Studied 143 patients (mean age 63 years) with documented CHD.
- Utilized the Beck Depression Inventory (BDI) to quantify depressive symptomatology.
Main Results:
- Patients with significant depressive symptoms (BDI ≥ 10) exhibited attenuated FMD compared to non-depressed patients (p = 0.001).
- Antidepressant medication use was associated with improved FMD (p < 0.05).
Conclusions:
- Endothelial dysfunction may partially mediate the elevated cardiovascular event risk observed in CHD patients with depressive symptoms.
- Findings suggest a potential therapeutic target for improving cardiovascular outcomes in this population.
Objectives:
The purpose of this study was to assess whether depressive symptomatology was associated with vascular endothelial dysfunction in patients with coronary heart disease (CHD).
Background:
In patients with CHD, the presence of depression is associated with a two to four times increased risk of mortality, but the disease pathways involved are uncertain. Endothelial dysfunction is an established risk factor for cardiovascular events in patients with CHD.
Methods:
Flow-mediated dilation (FMD) of the brachial artery, a measure of endothelial function, was assessed in 143 patients (99 men, 44 women), ages 40 to 84 years (mean age, 63 +/- 10 years), with documented CHD.
Results:
Patients with significant depressive symptomatology, as indicated by a Beck Depression Inventory (BDI) score > or = 10 (n = 47) showed attenuated FMD (p = 0.001) compared with patients that were not depressed (BDI < 10; n = 96). The use of antidepressant medication was associated with improved FMD (p < 0.05).
Conclusions:
The increased risk of cardiovascular events in CHD patients with elevated symptoms of depression may be mediated, in part, by endothelial dysfunction.
Related Concept Videos
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures
